Blog
RSS FeedPosted by Michael Wonder on 22 Sep 2023
PMPRB report shows increased plan costs, promising pharmaceutical innovation: expert
20 September 2023 - A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug ...
Posted by Michael Wonder on 21 Sep 2023
The Inflation Reduction Act and access to high cost cardiovascular therapies
20 September 2023 - On August 29, 2023, the Biden-Harris administration announced the first 10 drugs selected for Medicare price ...
Posted by Michael Wonder on 21 Sep 2023
Medicare’s historic prescription drug price negotiations
20 September 2023 - On 29 August 2023, the Biden administration announced the first 10 drugs whose prices will be ...
Posted by Michael Wonder on 14 Sep 2023
Inflation Reduction Act continues to lower out of pocket prescription drug costs for drugs with price increases above inflation
13 September 2023 - CMS announces savings for some people with Medicare on 34 Part B prescription drugs. ...
Posted by Michael Wonder on 13 Sep 2023
Merck can’t sue over drug pricing plan, HHS tells court
13 September 2023 - Company isn’t primary manufacturer, administration argues. ...
Posted by Michael Wonder on 12 Sep 2023
The Inflation Reduction Act will lead to fewer new medicines
11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in ...
Posted by Michael Wonder on 11 Sep 2023
Generic drugs should be cheap, but insurers are charging thousands of dollars for them
11 September 2023 - Health insurers mark up prices of generics for cancer, multiple sclerosis and other complicated diseases. ...
Posted by Michael Wonder on 11 Sep 2023
Yale experts discuss impact of Medicare price negotiation legislation
11 September 2023 - Following the announcement of the 10 drugs for which Medicare is authorised to negotiate prices, Yale experts ...
Posted by Michael Wonder on 08 Sep 2023
The 4 arguments you will hear against drug price negotiation
6 September 2023 - While government-negotiated prices will not take effect until 2026, the list of specific drugs makes this legislative ...
Posted by Michael Wonder on 07 Sep 2023
Inflation Reduction Act may accelerate generic and biosimilar market entry, but questions remain around CMS guidance
5 September 2023 - Last week, the Centers for Medicare and Medicaid Services announced its selection of the first 10 prescription ...
Posted by Michael Wonder on 07 Sep 2023
Astellas withdraws lawsuit after evading Medicare drug price negotiations
6 September 2023 - Astellas was so sure that one of its drugs was going to be selected as part ...
Posted by Michael Wonder on 05 Sep 2023
Novartis sues US Government over Medicare drug price regulation
1 September 2023 - Swiss drug maker Novartis on Friday said it had sued the US Government in an attempt ...
Posted by Michael Wonder on 04 Sep 2023
What to expect from the emerging battle royale over drug prices
2 September 2023 - On 29 August, the Biden administration announced the first 10 drugs whose prices will be negotiated with ...
Posted by Michael Wonder on 02 Sep 2023
US Senators push drug makers for details on low cost insulin programs
31 August 2023 - Two US Senators are demanding that the nation's three largest insulin makers, Novo Nordisk, Eli Lilly ...
Posted by Michael Wonder on 30 Aug 2023
Medicare should negotiate with drug makers. But not set prices.
30 August 2023 - New rules in America threaten to deter innovation. ...